Walleye Capital LLC Essa Pharma Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.5 - $4.82 $324,553 - $1.04 Million	-216,369 Reduced 91.24%	20,784 $52,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.44 $232,330 - $456,694	132,760 Added 127.17%	237,153 $432,000
Q2 2022 Aug 08, 2022	BUY	$3.15 - $7.94 $141,762 - $357,331	45,004 Added 75.78%	104,393 $329,000
Q1 2022 May 16, 2022	BUY	$6.18 - $14.44 $367,024 - $857,577	59,389 New	59,389 $367,000
Q4 2021 Mar 03, 2022	SELL	$7.8 - $14.38 $884,863 - $1.63 Million	-113,444 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.76 - $29.37 $880,325 - $3.33 Million	113,444 New	113,444 $908,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $80.7M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.